TSC2 and epilepsy: Since the prevalence of each lesion differs depending on age and causative gene (TSC1 or TSC2), when the patients were divided into those aged 10 and over, TSC2 patients, and TSC1 patients; there was no significant difference in prevalence in at least one category for all symptoms and lesions, other than epilepsy.